Publisher
Springer Berlin Heidelberg
Reference64 articles.
1. Abraham, D. J., Rutherford, J. S., Rosenstein, R. D.: Single crystal studies of chemothera- peutic agents. I. The structure of l-(2-chloroethyl)-3-(5-carbamoylimidazol-4-yl)-zl2-l,2,3- triazolinium chloride. J. med. Chem. 12, 189–190 (1969).
2. Burchenal, J. H., Dagg, M. K., Beyer, M., Stock, C. C.: Chemotherapy of leukemia. VII. Effect of substituted triazenes on transplanted mouse leukemia. Proc. Soc. exp. Biol. (N.Y.) 91, 398–401 (1956).
3. Burke, P. J., Mccarthy, W.H., Milton, G.W.: Imidazole carboxamide therapy in advanced malignant melanoma. Cancer 27, 744–750 (1971).
4. Clarke, D. A., Barclay, R. K., Stock, C. C., Rondestvedt, C. S., Jr.: Triazenes as inhibitors of mouse sarcoma 180. Proc. Soc. exp. Biol. (N.Y.) 90, 484–489 (1955).
5. Cowan, D. H., Bergsagel, D. E.: Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-l-triazeno)imidazole-4-carboxamide (NSC-45388). Cancer Chemother. Rep. 55, 175–181 (1971).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Chemistry of DNA Damage by Antitumour Drugs;Molecular Aspects of Anti-Cancer Drug Action;1983